Chemotherapy | New Drugs | New Studies | Research | Treatments | Updates
Orphan Drug Improves Mesothelioma Survival in Phase II Trial
T. Researchers with the National Cancer Institute report that, when administered along with the traditional chemotherapy, amatuximab appears to be…